Washington: An expert committee convened by the US Food and Drug Administration (FDA) has voted heavily in favour of recommending the Pfizer-BioNTech COVID-19 vaccine for emergency use approval. The final ...
New York: Pfizer has decided to keep a differential pricing on its COVID-19 vaccine, which will be based on a country's GDP. CEO Albert Bourla has said the vaccine will ...
New York: The US Food and Drug Administration (FDA) has revealed that the COVID-19 vaccine developed by Pfizer-BioNTech saw four volunteers developing temporary facial paralysis or Bell's palsy during the ...
London: Regulators have added allergic reaction warnings for Pfizer's COVID-19 vaccine. Anyone with a history of significant allergic reactions are advised not to have the vaccine shot. Two NHS staff ...
London: Dr Hari Shukla, 87 and his wife Ranjan, 83-year-old wife from the northeast of England on Tuesday became the first Indian-origin couple in the world to get a vaccine ...
Hyderabad: Pfizer and the Serum Institute of India (SII) had already sought emergency use approval for their COVID-19 vaccines from the Drug Controller General of India (DCGI). Now, Hyderabad-based Bharat ...
New Delhi: The Serum Institute of India (SII) has sought emergency use authorisation of its vaccine candidate Covishield in the country. The Pune-based SII is conducting the India trials of ...
London: The frontrunners in the race to develop a coronavirus vaccine continue to show positive results. After Pfizer and Moderna reported extremely encouraging data from final-stage trials of their COVID-19 ...
New York: Pfizer Inc PFE.N and BioNTech 22UAy.DE could get emergency US and European approval for their COVID-19 vaccine in December after final trial results showed a resounding 95 per ...
London: Pharma major Pfizer on Wednesday reported that its COVID-19 vaccine is 95 per cent effective in phase 3 trials and would be applying for emergency US authorization within days. ...
Copyright © 2024 Frontier Media
